Meaning and Purpose (MaP) Therapy in Patients with Advanced Cancer: A Randomised Controlled Trial targeting psychological wellbeing

Not Applicable

• Conditions: Advanced cancer; Distress; Demoralization; Cancer - Any cancer

• Registration Number: ACTRN12618001751268
• Lead Sponsor: niversity of Notre Dame Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-24
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

•aged 18 years or older; No upper age limit
•advanced cancer with a prognosis of 2 years or less;
•Distress Thermometer score greater tan or equal to 4
•fluent in spoken and written English; and
•ability to give written informed consent
•willingness to participate in and comply with the study.

Exclusion Criteria

•known cognitive impairment that would interfere with participation;
•too unwell or frail (e.g., impairment associated with co-morbid conditions) to participate as determined by treating clinicians.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post Traumatic Growth Inventory; subscales of appreciation of life and new possibilities[3 months post intervention]

Secondary Outcome Measures

Name	Time	Method
ife Attitudes (LAP-R) (subscales of choice and goal seeking), [3 months post intervention];FACIT-SP Spiritual wellbeing[3 months post intervention];McGill Existential Quality of Life (existential wellbeing and quality f life)[3 months post intervention];DS-II (Demoralization)[3 months post intervention];PHQ-9 (depression)[3 months post intervention];DADDS (Death and dying distress scale)[3 month post intervention]